BridgeBio have substantially boosted the development of an innovative therapy for ATTR-CM, utilizing the investigational drug. Early patient data suggests significant improvements for those affected by this debilitating https://biotech265604.digitollblog.com/42056498/bridgebio-progresses-attr-cm-therapy-using-the-therapy